Showing results (241-250 of 541) with videos related to

Sort By:
Pageof 55
Drugs - Real World Outcomes|May 30, 2025
Understanding Underreporting of Adverse Drug Reactions in the Philippines: A Mixed Methods StudyMark Ryann A Lirasan, Mark Harvey B Adamson, Vieno Gino Cruz, et al.
Drugs - Real World Outcomes|October 7, 2025
Cost Differences Between Oral Anticoagulation Therapies in Patients with Atrial Fibrillation in FinlandOssi Lehtonen, Olli Halminen, K E Juhani Airaksinen, et al.
Drugs - Real World Outcomes|June 10, 2023
Prescribing Pattern and Associated Factors in Community Pharmacies: A Cross-Sectional Study Using AWaRe Classification and WHO Antibiotic Prescribing Indicators in Dire Dawa, EthiopiaBeyene Dereje, Alemseged Workneh, Alemayehu Megersa, et al.
Drugs - Real World Outcomes|March 11, 2026
Time to Treatment Discontinuation and Cost Effectiveness of Third-Line Therapies in Advanced Colorectal Cancer: Real-World Evidence from the NIH All of Us Research ProgramPatrick J Kiel, Mark W McGiffin, Todd C Skaar, et al.
Drugs - Real World Outcomes|April 9, 2026
Regional Trends in the Opioid Epidemic Using Safety Signals of Drug Abuse and Dependence: A Disproportionality Analysis Using VigiBaseBohyun Suh, Hyung Suk Oh, Ju-Young Shin, et al.
Drugs - Real World Outcomes|March 27, 2026
Drug Utilization Pattern of Proton Pump Inhibitors in Patients with Acid Peptic Disease and Comorbidities in India: A Real-World Electronic Medical Records-Based StudyYogesh Garje, Tanish Modi, Mudit Sabharwal, et al.
Drugs - Real World Outcomes|May 10, 2024
Safety of Combined Statin and Fibrate Therapy: Risks of Liver Injury and Acute Kidney Injury in a Cohort Study from the Shizuoka Kokuho DatabaseYohei Sobukawa, Taichi Hatta, Daito Funaki, et al.
Drugs - Real World Outcomes|May 10, 2024
Treatment Patterns, Acute Healthcare Resource Use, and Costs of Patients with Treatment-Resistant Depression Completing Induction Phase of Esketamine in the United StatesLisa Harding, Kruti Joshi, Maryia Zhdanava, et al.
Drugs - Real World Outcomes|May 10, 2024
Economic Evaluation of Nirmatrelvir/Ritonavir Among Adults Against Hospitalization During the Omicron Dominated Period in Malaysia: A Real-World Evidence PerspectiveEe Vien Low, Hoon Shien Teh, Nicholas Yee Liang Hing, et al.
Drugs - Real World Outcomes|October 29, 2023
Effectiveness of Dapagliflozin as Add-On to Metformin with or without Other Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus: A Multicentre, Retrospective, Real-World Database StudyBipin Sethi, Rakesh Sahay, Mangesh Tiwaskar, et al.
Pageof 55